Department of Medicine, Division of Hematology and Medical Oncology, New York University, Grossman School of Medicine, NY, New York, USA.
Department of Medicine, Division of Hematology and Medical Oncology, New York University, Grossman School of Medicine, NY, New York, USA; Perlmutter Cancer Center, NYU Langone Health, NY, New York, USA.
Blood Rev. 2024 May;65:101169. doi: 10.1016/j.blre.2024.101169. Epub 2024 Jan 8.
In the recent few decades, outcomes in patients diagnosed with hematological malignancies have been steadily improving. However, the improved prognosis does not distribute equally among patients from different backgrounds. Besides cancer biology, demographic and geographic disparities have been found to impact overall survival significantly. Specifically, patients from underrepresented minorities including Black and Hispanics, and those with uninsured status, having low socioeconomic status, or from rural areas have had worse outcomes historically, which is uniformly true across all major subtypes of hematological malignancies. Similar discrepancy is also seen in the health care professional field, where a gender gap and a disproportionally low representation of health care providers from underrepresented minorities have been long existing. Thus, a comprehensive strategy to mitigate disparity in the health care system is needed to achieve equity in health care.
在最近几十年中,被诊断患有血液系统恶性肿瘤的患者的治疗结果一直在稳步改善。然而,这种改善的预后在不同背景的患者中并不均等分布。除了癌症生物学因素外,人口统计学和地理差异也被发现对总生存率有重大影响。具体而言,来自代表性不足的少数群体(包括黑人和西班牙裔)的患者,以及没有保险、社会经济地位较低或来自农村地区的患者,历史上的预后更差,这在所有主要类型的血液系统恶性肿瘤中都是普遍存在的。这种差异在医疗保健专业领域也存在,长期以来,该领域一直存在性别差距和代表性不足的少数族裔医疗保健提供者的比例不成比例。因此,需要制定一项综合策略来减轻医疗保健系统中的差异,以实现医疗保健公平。